Eventide Asset Management, LLC Beam Therapeutics Inc. Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$23.01 - $32.46 $4.55 Million - $6.42 Million
-197,843 Reduced 43.08%
261,360 $6.29 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $5.79 Million - $9.38 Million
192,178 Added 71.97%
459,203 $14.1 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $10.6 Million - $18.8 Million
267,025 New
267,025 $12.7 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email